You have 7 free searches left this month | for more free features.

Chemotherapy, surgery and non-pharmacological treatment of ovarian cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovary Cancer, Endometrial Cancer, Uterine Cancer Trial in Chicago (FAST Intervention)

Not yet recruiting
  • Ovary Cancer
  • +2 more
  • FAST Intervention
  • Chicago, Illinois
    Northwestern Memorial Hospital
Aug 4, 2023

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Ovarian Cancer Trial in Houston (Cytoreductive surgery)

Recruiting
  • Ovarian Cancer
  • Cytoreductive surgery
  • Houston, Texas
    MD Anderson Cancer Center
Jul 28, 2022

Ovarian Cancer, Drug Related Tumor/Cancer Trial (secondary cytoreductive surgery, chemo)

Not yet recruiting
  • Ovarian Cancer
  • Drug Related Neoplasm/Cancer
  • (no location specified)
Jan 28, 2023

Ovarian Cancer Trial in Shanghai (Paclitaxel, Carboplatin, debulking surgery)

Recruiting
  • Ovarian Cancer
  • Paclitaxel, Carboplatin
  • debulking surgery
  • Shanghai, Shanghai, China
    Fudan university shanghai cancer center, Deparment of gynecologi
May 7, 2022

Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)

Active, not recruiting
  • Ovarian Cancer
  • +2 more
  • carboplatin and paclitaxel followed by surgery
  • Bologna, Italy
  • +4 more
Dec 28, 2022

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial (Cisplatin, No treatment)

Not yet recruiting
  • Stage III Ovarian Cancer
  • +5 more
  • (no location specified)
Dec 12, 2022

NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Iowa City, Iowa
    University of Iowa
Oct 10, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Ovarian Cancer Trial in Worldwide (cisplatin)

Recruiting
  • Ovarian Cancer
  • New York, New York
  • +20 more
Oct 17, 2022

Ovarian Cancer, Intraperitoneal Chemo Trial in Montpellier (Intraperitoneal chemo during surgery)

Recruiting
  • Ovarian Cancer
  • Intraperitoneal Chemotherapy
  • Intraperitoneal chemotherapy during surgery
  • Montpellier, France
    Institut du Cancer de Montpellier - Val d'Aurelle
Mar 11, 2022

Ovarian Cancer Trial in Zagazig (laparoscopy then primary cytoreductive surgery, laparoscopy then neoadjuvant chemo followed by

Completed
  • Ovarian Cancer
  • laparoscopy then primary cytoreductive surgery
  • laparoscopy then neoadjuvant chemotherapy followed by interval cytoreductive surgery
  • Zagazig, Sharkia, Egypt
    Faculty of Medicine, Zagazig Univeristy
Oct 1, 2022

Measure for Advanced Ovarian Cancer Patients Receiving Surgical

Not yet recruiting
  • Ovarian Cancer
  • +3 more
    • (no location specified)
    Mar 2, 2022

    Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)

    Withdrawn
    • Colorectal Cancer
    • Metastatic Cancer
    • FOLFIRI regimen
    • +7 more
    • Boulogne Billancourt, France
      Hopital Ambroise Pare
    Aug 26, 2022

    NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)

    Recruiting
    • NSCLC
    • Neoadjuvant Therapy
    • Serplulimab and neoadjuvant therapy
    • surgical resection of lung cancer
    • Hangzhou, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    May 22, 2023

    Cancer, Risk of Premature Ovarian Failure, Fertility Preservation Trial in New York (surgery to remove ovaries or high dose

    Recruiting
    • Cancer
    • +2 more
    • surgery to remove ovaries or high dose chemotherapy
    • New York, New York
      Ronald O. Perelman and Claudia Cohen Center for Reproductive Med
    Jan 18, 2023

    Ovarian Cancer Trial in Naples (Olaparib, Chemotherapy drug)

    Recruiting
    • Ovarian Cancer
    • Naples, Italy
      IRCCS Istituto Nazionale Tumori di Napoli
    Feb 24, 2022

    Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

    Active, not recruiting
    • Fallopian Tube Clear Cell Adenocarcinoma
    • +22 more
    • Laboratory Biomarker Analysis
    • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
    • Rochester, Minnesota
      Mayo Clinic
    Oct 7, 2022

    Ovarian Cancer, Hyperthermic Intraperitoneal Chemo, Paclitaxel Trial in Guangzhou (Hyperthermic Intraperitoneal Paclitaxel

    Recruiting
    • Ovarian Cancer
    • +2 more
    • Hyperthermic Intraperitoneal Paclitaxel Combined With Cisplatin
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen Memorial Hospital
    Nov 11, 2022

    Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Shibin Al Kawm (secondary cytoreductive surgery, Chemotherapy)

    Withdrawn
    • Ovarian Cancer
    • Recurrent Ovarian Carcinoma
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University, Faculty of medicine
    Apr 9, 2022

    Locally Advanced, NSCLC Trial in Shanghai (drug, procedure, radiation)

    Recruiting
    • Locally Advanced
    • Non-small Cell Lung Cancer
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Mar 14, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery, Neoadjuvant

    Not yet recruiting
    • Ovarian Cancer
    • +2 more
    • Primary debulking surgery
    • +2 more
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Jan 17, 2022

    NSCLC Trial (Durvalumab)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • (no location specified)
    Jun 22, 2023

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Houston, Texas
    • +4 more
    Oct 20, 2022